CMXHF (CMXHF) Stock Price & Analysis
CMXHF (CMXHF) rose 0.00% to USD 81.96 as of July 25, 2026 at 03:03 UTC, according to Nexqual real-time market data.
CMXHF last closed at USD 81.96; the session ranged USD 77.86–77.89 on volume of 200 shares. Market capitalization is $39.25B, with a 52-week range of USD 63.84–184.09 (OQX). Source: Nexqual, July 25, 2026 at 03:03 UTC.
Key Statistics (as of July 25, 2026 at 03:03 UTC)
| Price | USD 81.96 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 81.96 |
| Open | USD 77.86 |
| Day Range | USD 77.86 – 77.89 |
| 52-Week Range | USD 63.84 – 184.09 |
| Volume | 200 shares |
| Market Cap | $39.25B |
| Exchange | OQX |
Technical Analysis (CMXHF)
Nexqual's technical model rates CMXHF "NEUTRAL" based on 3 bullish and 3 bearish signals across 125 daily candles, as of July 25, 2026 at 03:03 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 54.24 (neutral) |
| vs SMA50 | Above (USD 76.47) |
| MACD | 1.44 (positive) |
Analyst Ratings (CMXHF)
Wall Street analysts rate CMXHF "None", per Nexqual as of July 25, 2026 at 03:03 UTC.
| Consensus Rating | None |
|---|
Earnings (CMXHF)
Source: Nexqual, July 25, 2026 at 03:03 UTC.
Financials & Fundamentals (CMXHF)
| Total Revenue | $15.41B |
|---|---|
| Revenue Growth (YoY) | -1.80% |
| Gross Margin | +51.87% |
| Operating Margin | +31.65% |
| Profit Margin | +9.06% |
| ROE | +6.66% |
| Debt / Equity | 54.44 |
| Current Ratio | 2.57 |
| Total Cash | $1.14B |
| Total Debt | $11.14B |
| Free Cash Flow | $1.85B |
Source: Nexqual, July 25, 2026 at 03:03 UTC.
Financial Health Score (CMXHF)
Nexqual rates CMXHF's overall financial health "Solid" across five dimensions, as of July 25, 2026 at 03:03 UTC.
| Growth | Solid — Revenue +5% YoY (annual) |
|---|---|
| Profitability | Strong — Gross margin 52%, operating 32% |
| Balance Sheet | Strong — $1.14B cash vs $11.1B debt |
| Cash Flow | Solid — FCF $1.85B, 12% margin |
| Efficiency | Mixed — ROE 7%, ROA 6.6% |
Ownership (CMXHF)
| Insider Ownership | +0.03% |
|---|---|
| Institutional Ownership | +40.64% |
| Shares Outstanding | 478.91M |
| Float | 481.75M |
Source: Nexqual, July 25, 2026 at 03:03 UTC.
Leadership (CMXHF)
CMXHF is led by Gordon Naylor BEng (Hons), C.P.A., DipCompSc (age 62), CEO, MD & Director, per Nexqual as of July 25, 2026 at 03:03 UTC.
| CEO, MD & Director | Gordon Naylor BEng (Hons), C.P.A., DipCompSc (age 62) |
|---|---|
| Chief Financial Officer | Ken Lim (age 51) |
| Executive VP & COO | Mary Oates (age 62) |
| Senior Vice President of Research & Development Strategic Operations | Deirdre BeVard |
Major Backers & Investors (CMXHF)
Notable institutional backers of CMXHF include Fidelity, J.P. Morgan Exch-Trd Fd. TRT-JPMorgan BetaBuilders Developed Asia Paci, MFS SERIES TRUST I-MFS Research International Fund, according to Nexqual as of July 25, 2026 at 03:03 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Fidelity | 0.38% |
| J.P. Morgan Exch-Trd Fd. TRT-JPMorgan BetaBuilders Developed Asia Paci | 0.29% |
| MFS SERIES TRUST I-MFS Research International Fund | 0.23% |
| Charles Schwab | 0.22% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 2.69% |
| BlackRock | 1.37% |
Source: Nexqual, July 25, 2026 at 03:03 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| CSLLY | CSL Ltd. | USD 20 | ▼ 3.85% |
| MKGAF | Merck KGaA | USD 159.92 | ▲ 3.79% |
| NPPXF | NTT Inc. | USD 0.91 | ▼ 1.09% |
| GNMSF | Genmab A/S | USD 274.5 | ▲ 0% |
| DGEAF | Diageo plc | USD 20.28 | ▼ 5.14% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 03:03 UTC. This page is informational and not investment advice.